Alliance Pharma plc announced delay in publication of preliminary earnings results for the year ended December 31, 2023. The company announced that the preliminary results for the year ended 31 December 2023 will not be published on 23 April 2024. The company now anticipate that the results will be published in early May, and The company expects to provide an update on the date of publication on 26 April 2024.Further to the announcement on 5 April 2024, whilst the audit of the results is at an advanced stage, the Group's auditor, Deloitte LLP, has requested additional time to finalise its work.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
33.5 GBX | +9,638.37% | -8.97% | -17.28% |
May. 30 | Amberen, Brand of Alliance Pharma plc, Announces Launch of Amberen ENERGY MOOD SLEEP Gummies | CI |
May. 21 | Alliance Pharma plc Announces the Appointment of Nicholas John Sedgwick as Director | CI |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.28% | 237M | |
+19.64% | 43.03B | |
+23.86% | 22.7B | |
+17.33% | 15.07B | |
+23.64% | 14.77B | |
+59.16% | 13.05B | |
-0.05% | 6.79B | |
-14.19% | 6.58B | |
-8.87% | 5.73B | |
+13.42% | 5.5B |
- Stock Market
- Equities
- APH Stock
- News Alliance Pharma plc
- Alliance Pharma plc Announces Delay in Publication of Preliminary Earnings Results for the Year Ended December 31, 2023